Medifast, Inc. reports developments as a metabolic health and wellness company built around the OPTAVIA science-backed, coach-guided lifestyle system. Its updates center on revenue trends, gross margin, active earning coaches, coach productivity and the company's shift toward metabolic health amid changes in weight-loss demand and GLP-1 medication adoption.
Recurring company news also covers OPTAVIA program evidence, nutrition and habit-creation offerings, HSA/FSA reimbursement availability on select insurance plans, independent coach community initiatives, media content tied to metabolic health, and governance matters such as board nominations and stockholder cooperation agreements.
On August 11, 2021, Medifast (NYSE: MED) launched the OPTAVIA app, enhancing its digital services for Clients and Coaches. This app, which has already been downloaded nearly 150,000 times, offers features like Lean & Green recipes, order history, and account management. The initiative is part of Medifast's strategy to improve digital infrastructure, enabling Coaches to better support Clients. The app's development reflects a commitment to continuous improvement based on user feedback, with plans for further enhancements and the upcoming OPTAVIA Connect app aimed at boosting Coach productivity.
Medifast (NYSE: MED) reported strong Q2 results for 2021, with revenue surging 79.2% to $394.2 million, driven by a 62.2% increase in active OPTAVIA Coaches to 59,200. Net income rose 114.1% to $47 million, translating to earnings per share (EPS) of $3.96. The company achieved a gross profit increase of 84.4%, reaching $293.7 million. Despite a 77.0% rise in SG&A expenses, operating income improved significantly. For FY 2021, Medifast anticipates revenue between $1.425 billion and $1.525 billion, with EPS guidance of $12.70 to $14.17.
Medifast (NYSE: MED) successfully hosted its annual OPTAVIA Convention from July 29 to August 1, 2021, in a hybrid format, attracting over 15,000 registrants. The event featured Coach-led educational sessions, community engagement activities, and celebrations for independent Coaches and their clients. A philanthropic fundraising initiative raised over $100,000 to provide nutritious meals for children in need, contributing to a total of 8 million meals funded to date. CEO Dan Chard emphasized the importance of connection and support amidst the challenges brought by the pandemic.
Medifast, Inc. (NYSE: MED) announced it will disclose its financial results for Q2 2021 on August 4, 2021, after market close. The conference call for discussing these results will start at 4:30 p.m. ET on the same day. Participants will include Chairman and CEO Dan Chard, and CFO Jim Maloney. The call will be live-streamed on the company's Investor Relations page and available for playback afterward. Medifast is recognized for its health and wellness brand OPTAVIA® and has been ranked among FORTUNE's 100 Fastest-Growing Companies in 2020.
Summary not available.
Medifast has declared a $1.42 quarterly cash dividend for stockholders, payable on August 6, 2021, to those on record by June 22, 2021. The company aims to maintain a quarterly dividend program, subject to Board discretion based on various factors. Medifast, traded on NYSE under the symbol MED, is known for its health and wellness community, OPTAVIA, and has been recognized as one of the 100 Fastest-Growing Companies by Fortune in 2020. Investors should note potential fluctuations in dividend declarations based on corporate performance.
Medifast, Inc. (NYSE: MED) reported exceptional first-quarter results for 2021, showcasing a 90.9% increase in revenue to $340.7 million. Active earning OPTAVIA Coaches grew by 61.0% to 52,500, while revenue per coach jumped 21.0% to $6,454. Net income soared by 122.2% to $41.1 million, resulting in an EPS of $3.46. The company anticipates full-year revenue of $1.4 billion to $1.475 billion and EPS between $12.69 and $14.14. Despite solid performance, the gross profit margin declined slightly to 73.0%.
Medifast, Inc. (NYSE: MED) will announce its first-quarter financial results for the period ending March 31, 2021, on May 4, 2021, after market close. This announcement will be followed by a conference call at 4:30 p.m. ET on the same day, featuring CEO Dan Chard and CFO Jim Maloney. The call will be accessible via the company's Investor Relations page. Medifast is recognized for its OPTAVIA® health and wellness community, known for its scientifically developed products and support system aimed at achieving lifelong transformation.
Summary not available.
Medifast, Inc. (NYSE: MED) announced a quarterly cash dividend of $1.42 per share, payable on May 6, 2021 to stockholders of record by March 30, 2021. The company aims to maintain quarterly dividend payments, subject to the Board's discretion based on relevant factors. Medifast operates the OPTAVIA® community, promoting health and wellness through scientifically developed products and coaching. Ranked among FORTUNE's fastest-growing companies, Medifast emphasizes its commitment to shareholder returns.